Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 January 2020 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Soil Confrence at UFS
At the Combined Congress with the theme ‘Basic and applied sciences – Fundamentals of sustainable agriculture’, were from the left: Prof Klaus Kellner, Prof Prakash Naidoo, Dr Cobus Botha from the Agriculture Research Council, Prof Vaughan Hattingh, and Mr Matome Ramokgopa.

“We are at the beginning of a new decade that will in all likelihood be pivotal for aspects such as food security, climate change, and the sustainable use of natural resources – aspects that the societies you represent are of course keenly involved with – and in terms of which you can play an increasingly valuable role.” 

These were the words of Vice-Rector: Operations at the University of the Free State (UFS), Prof Prakash Naidoo, on opening a Combined Congress of the Soil Science Society of South Africa (SSSSA), the South African Society of Crop Production (SASCP), the Southern African Weed Science Society (SAWSS), and the Southern African Society for Horticultural Sciences (SASHS).

The UFS Department of Soil, Crop and Climate Sciences is hosting the congress, with scientific content of four disciplines (soil, crop, weed, and horticulture) presented by both local and international guest speakers.

The theme of this year’s congress taking place on the UFS Bloemfontein Campus, is Basic and applied sciences – Fundamentals of sustainable agriculture.

Prof Naidoo continues: “It has been predicted that the world will need almost double the current food supply by 2050 to feed an ever-increasing world population. This clearly makes the scientific work done in the agricultural sector and the organisations affiliated with it, more vital than ever. We need to do what we can to ensure food security and sustainability.”

“A congress like yours is an opportunity to tap into the perspectives and research results of collaborators from different fields, and from different levels of skill and experience – with the aim of ultimately benefiting wider communities.”

Leader in agriculture sector

Prof Vaughan Hattingh, representing SASHS (Chief Executive Officer of Citrus Research International); Mr Matome Ramokgopa, representing SASCP (General Manager of Enza Zanden SA); and Prof Klaus Kellner, representing SSSSA (Department of Botany at the North-West University), delivered the combined opening address.

Prof Hattingh, speaking on ‘Industry–University partnership opportunity road ahead for horticultural research’, says citrus is a major horticultural product internationally and the biggest horticultural export from South Africa. The citrus industry, the second largest exporter of citrus in the world, generates R20 bn per year and is the biggest funder of research in this area. 

Prof Hattingh states that university partnerships, developing science to assist the industry, are key. “The future of horticultural industries and horticultural research at universities depends on successful university-industry partnerships.”

Mr Ramokgopa talked about ‘Innovative solutions for vegetable seed production for a growing population’, saying that Enza Zanden employed several techniques in vegetable production in response to the needs of retailers and consumers. These include smaller tomatoes (for snacking purposes), smaller leaf size of lettuce (thus a smaller area for decay), plastic-free packaging of cucumber with a longer shelf life, and more uniform onions (suitable for onion rings). 

Prof Kellner focused on ‘Scientifically sound policies and practices to ensure food security and sustainable agriculture’. He said: “It is getting warmer in Southern Africa and Europe. We need to realise it and adapt practices accordingly.”

More discussions on sustainable agriculture

Other interesting topics covered at the congress include, ‘Developing propagation technologies for indigenous plants used in the natural products industry’; ‘The influence of foliar and application rate of nitrogen fertiliser on seed and oil yield of canola’; ‘Sweet potato production in sacks: potential utilisation of limited space in rural, urban and peri-urban areas’; ‘The efficacy of postharvest wax application in the reduction of chilling injury incidence in lemon fruit’; and ‘Herbicide use within the commercial forestry sector in South Africa’.

Congress attendees can also look forward to the ‘Soil fertility and crop nutrition symposium: principles and practices’ on Wednesday 22 January 2020.

The congress kicked off on 21 January, and will come to an end on Thursday 23 January 2020. For more information on the sessions, see programme.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept